SEC Form 4 · accession 0001562180-16-002361
vTv Therapeutics Inc. · VTVT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Fry
Director
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 1:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director stock option (right to buy)F1 | $5.35 | May 12, 2016 | A | 17,500 | A | — | May 12, 2026 | Class A common stock | 17,500 | 17,500 | D |
Explanation of responses
- F1An option to acquire 138 shares is immediately vested on May 12, 2016. The remaining portion of the option grant (an option to acquire 17,362 shares) vests in monthly equal installments over the three year period beginning on May 12, 2016.